ArticleJournal of cellular and molecular medicine2020

A novel danshensu derivative ameliorates experimental colitis by modulating NADPH oxidase 4-dependent NLRP3 inflammasome activation.

Li-Long Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.